|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
10 May 2021 |
|
Main ID: |
NCT01306006 |
|
Date of registration:
|
24/02/2011 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
The Effect on Overall Mortality of a National Policy of Limiting Measles Vaccination to Children Below 12 Months of Age
MVEPI |
|
Scientific title:
|
The Effect on Overall Mortality of a National Policy of Limiting Measles Vaccination to Children Below 12 Months of Age |
|
Date of first enrolment:
|
February 2011 |
|
Target sample size:
|
3500 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT01306006 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
|
|
Phase:
|
Phase 4
|
|
|
Countries of recruitment
|
|
Guinea-Bissau
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Age 9-35 months, not yet received routine measles vaccination, resident in study area
Exclusion Criteria:
- To ill to be vaccinated (according to local practice)
Age minimum:
9 Months
Age maximum:
35 Months
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Mortality
|
|
Vaccines
|
|
Intervention(s)
|
|
Biological: Providing measles vaccine for all children 9-35 months who have not yet received a routine measles vaccine
|
|
Primary Outcome(s)
|
|
Mortality
|
|
Secondary Outcome(s)
|
|
Hospital morbidity
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|